[go: up one dir, main page]

UA99645C2 - Гель, имеющий противовоспалительное и противоаллергическое действие - Google Patents

Гель, имеющий противовоспалительное и противоаллергическое действие

Info

Publication number
UA99645C2
UA99645C2 UAA201011783A UAA201011783A UA99645C2 UA 99645 C2 UA99645 C2 UA 99645C2 UA A201011783 A UAA201011783 A UA A201011783A UA A201011783 A UAA201011783 A UA A201011783A UA 99645 C2 UA99645 C2 UA 99645C2
Authority
UA
Ukraine
Prior art keywords
inflammatory
gel
antiallergic
antiallergic gel
dimethyldihydropirimidone
Prior art date
Application number
UAA201011783A
Other languages
English (en)
Ukrainian (uk)
Inventor
Лев Давидович Раснецов
Яков Юделевич Шварцман
Ольга Константиновна Яшнова
Нина Борисовна Мельникова
Александр Александрович Волков
Original Assignee
Лев Давидович Раснецов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лев Давидович Раснецов filed Critical Лев Давидович Раснецов
Publication of UA99645C2 publication Critical patent/UA99645C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к области медицины и касается геля для внешнего применения, имеющего противовоспалительное и противоаллергическое действие, включающего в качестве активного вещества Ν-(β-оксиэтил)-4,6-диметилдигидропиримидон-2 (ксимедон), в качестве антигистаминного препарата - дифенгидрамин или клемастин, или цетиризин и гелевую основу, содержащую в качестве загустителя карбопол, а также полиэиленоксид с молекулярной массой 400-6000 Да, глицерин в количестве не больше 20 %, спирт этиловый в количестве не больше 41 % и воду очищенную.
UAA201011783A 2008-03-04 2009-03-03 Гель, имеющий противовоспалительное и противоаллергическое действие UA99645C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008108006/15A RU2370265C1 (ru) 2008-03-04 2008-03-04 Гель, обладающий противовоспалительным и противоаллергическим действием

Publications (1)

Publication Number Publication Date
UA99645C2 true UA99645C2 (ru) 2012-09-10

Family

ID=41065445

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201011783A UA99645C2 (ru) 2008-03-04 2009-03-03 Гель, имеющий противовоспалительное и противоаллергическое действие

Country Status (5)

Country Link
EA (1) EA017660B1 (ru)
GE (1) GEP20125719B (ru)
RU (1) RU2370265C1 (ru)
UA (1) UA99645C2 (ru)
WO (1) WO2009113910A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA019846B1 (ru) 2008-10-20 2014-06-30 Юнилевер Нв Противомикробная композиция, содержащая тимол и терпинеол, и ее применение
CA2801143C (en) 2009-09-24 2017-09-26 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
BR112012029746A2 (pt) * 2010-05-31 2016-08-09 Unilever Nv composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
EP2648681B1 (en) 2010-12-07 2015-01-07 Unilever N.V. An oral care composition
RU2450807C1 (ru) * 2011-05-11 2012-05-20 Общество с ограниченной ответственностью фирма "Вита" Стабилизированный фармацевтический состав с противогрибковым действием
IN2014MN00808A (ru) 2011-11-03 2015-09-04 Unilever Plc
RU2543326C2 (ru) * 2012-08-21 2015-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения зуда кожи
US8906951B1 (en) 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
MX366728B (es) * 2013-06-24 2019-07-22 Menlo Therapeutics Inc Uso de serlopitant como antagonistas del receptor nk-1 en prurito.
US9198898B2 (en) 2013-06-24 2015-12-01 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
RU2614961C1 (ru) * 2015-12-31 2017-03-31 Виктория Александровна Чумакова Способ изготовления фармацевтической композиции с фексофенадином, обладающей противоаллергическим и противовоспалительным действием

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2129002C1 (ru) * 1995-09-08 1999-04-20 Кутузова Ирина Владимировна Состав для лечения ран, ожогов, аллергических контактных дерматитов
RU2236845C2 (ru) * 2002-04-17 2004-09-27 Ставропольское научно-производственное объединение "Пульс" Противоожоговый гель и способ его получения
RU2280438C2 (ru) * 2004-01-13 2006-07-27 Государственное Предприятие "Государственный Научный Центр Лекарственных Средств" (Гнцлс) Средство "форидон-гель" для лечения и профилактики сердечно-сосудистых заболеваний
RU2317811C1 (ru) * 2006-06-19 2008-02-27 Лев Давидович Раснецов Фармацевтическая композиция для лечения ожогов (варианты) и способ ее получения (варианты)

Also Published As

Publication number Publication date
WO2009113910A1 (ru) 2009-09-17
EA201001324A1 (ru) 2011-02-28
RU2370265C1 (ru) 2009-10-20
EA017660B1 (ru) 2013-02-28
GEP20125719B (en) 2012-12-25

Similar Documents

Publication Publication Date Title
UA99645C2 (ru) Гель, имеющий противовоспалительное и противоаллергическое действие
AR062000A1 (es) Formulaciones de modificador de respuesta inmune
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
WO2007093450A3 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
MY148496A (en) Dpp iv inhibitor formulations
CL2008001114A1 (es) Compuestos derivados de bencimidazol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como vejiga sobreactiva, dolor, obesidad, convulsiones, entre otras.
PE20140960A1 (es) Formulaciones que comprenden un inhibidor de dpp4
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
TW200800987A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
MX354416B (es) Formulaciones a base de nalbufina y sus usos.
MXPA05010607A (es) Composiciones de distribucion de farmacos de ester de alfa-hidroxiacido y metodos de uso.
WO2008136034A3 (en) Ophthalmic compositions for the treatment of ocular hypertension and glaucoma
TW200716204A (en) Pharmaceutical composition
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
WO2008152334A3 (fr) Nouveaux dérivés d'acide 3-phenyl acrylique activateurs des récepteurs de type ppar, leur méthode de préparation et leur utilisation dans des compositions cosmétiques ou pharmaceutiques
SG162766A1 (en) Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
MY142792A (en) Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
ATE531703T1 (de) Benzochromenderivate
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
MY146803A (en) Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
CY1107277T1 (el) Βενζισοξαζολες
AR055107A1 (es) Furoato de n-{2-[((2s)-3-{[1-(4-clorobencil)piperidin-4-il]amino}-2-hidroxi-2-metilpropil)oxi]-4-hidroxifenil} acetamida,composiciones farmaceuticas que los contienen y usos para tratar afecciones o enfermedades donde actuan como moduladores del receptor de quimioquina 1(ccr1)